Home/BioAge Labs/Paul Rubin

PR

Paul Rubin

Chief Medical Officer

Therapeutic Areas

Metabolic Cardiovascular Ophthalmology

BioAge Labs Pipeline

Drug	Indication	Phase
BGE-102	Cardiovascular Risk Reduction	Phase 1b/2a
Apelin Receptor Agonist	Obesity (Exercise Mimetic)	Preclinical

Leadership Team at BioAge Labs

Kristen Fortney

Chief Executive Officer & Co-Founder

General Counsel

View full BioAge Labs profile